Navigation Links
EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
Date:6/4/2009

VIENNA, Austria, June 4 /PRNewswire/ -- EUCODIS Bioscience, a company developing enzymes for the chemical, the pharmaceutical, and other industries, announced today that it has successfully launched its first commercial enzyme, a beta-lactamase. The product is manufactured by EUCODIS Bioscience and can be supplied in a GMP-compliant formulation. The Company will market its beta-lactamase to antibiotics manufacturers to improve quality control, to the diagnostics industry, and to research organizations. The Company estimates that its beta-lactamase has a market potential of up to EUR 5 million.

"The launch of a beta-lactamase for the antibiotics industry and other uses opens a new phase in the development of our organization," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "The EUCODIS Bioscience team has demonstrated its capacity to cover the whole value-chain of an integrated enzyme supplier, from enzyme development, to manufacturing, and to marketing. This success adds momentum to our efforts to bring to market further products that we are currently developing. We will continue to provide our development expertise and our technology to industrial partners that want to increase their research and development efficiency."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.

Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional ventu
'/>"/>

SOURCE EUCODIS Bioscience
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EUCODIS Bioscience Signs Research Agreement With Genencor
2. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
3. EUCODIS Bioscience Appoints Thomas Fischer as Chief Financial Officer
4. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
5. Regado Biosciences Establishes Medical Advisory Board
6. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
7. YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING
8. Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
9. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
10. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
11. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...R TOLEDO recently announced that a free webinar, &...g At-Line Particle Characterization”, will b... the application of in situ particle characterizat...timize a series of roller compaction runs while va...tion forces. , (PRWEB) No...
(Date:11/19/2009)...19 Dr. Mate Hidvegi, inventor of A...press release issued on November 17 by Biropharma ... false and self-serving statements about its U.S. ...i stated from his office in Budapest, Hungary: ,...does not apply to AveULTRA, www.aveultra.com , ...
(Date:11/19/2009)...ny, November 19 MONITORING FORCE G...h, 2009 Flibanserin in the,indication treatment-re...disease for orphan drug status designation with th...ed dyskinesia is a complication of the mainstay,tr...en to some of those,affected, since it may be disa...
(Date:11/19/2009)...ia, November 19 AFFiRiS AG will fo... candidate at an unexpectedly early,stage of devel...nter into,Phase II clinical trial early in 2010. T...e completion of two Phase I trials with the candid...ision on the first interim,analysis of the seconda...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...RNewswire-FirstCall/ -- Genesis,Pharmaceuticals En...is" or,the "Company"), a U.S. pharmaceutical compa...epublic of China, today announced the launch of it...ttp://www.genesispharmaceuticals.com ., The webs...rate history,current products and recent news. The...
...stems (http://www.altogen.com ),announced launch ...or use,in laboratories and research facilities for...laboratory methods used to introduce DNA and RNA m...kes it possible to cross the,cellular barriers and...,into the cells for research or therapeutic purpos...
...apeutics,Inc., (Nasdaq: NLTX ), announced today t...resent at the following upcoming investor conferen...Conference at 2:25 p.m. ET,in the Kennedy II room ...n,New York, NY., -- Lazard Capital Markets 5th An...esday, November 19, 2008 in the La Maisonette I ro...
Other Biology Technology:Genesis Pharmaceuticals Launches New Corporate Website 2Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent 2Nile Therapeutics to Present at Two Upcoming Investor Conferences 2
(Date:11/19/2009)... of the last ice age, North America,s vast assembl...res as mammoths, mastodons, camels, horses, ground... slide to extinction. , And when their populatio...ge animals equaled or surpassed Africa,s wildlife-...el ecosystem emerged as broadleaved trees once kep...
(Date:11/19/2009)...he offspring of two inbred strains tend to be supe...gene-level variability that leads to this phenomen...t our ability to custom-tailor crops for specific ...sumption or high glucose content for biomass fuel....ce of the common corn strain B73, University of Mi...
(Date:11/19/2009)...iana Tech University has found that a naturally oc...against giant salvinia. , Giant salvinia is a no... sunlight penetration into bodies of water, alteri...s been reported that giant salvinia can double in ...fessor of biological sciences at Louisiana Tech, s...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Microorganism may provide key to combating giant salvinia throughout Louisiana 2Severe COPD may lead to cognitive impairment 50929 1Severe COPD may lead to cognitive impairment 50929 2Severe COPD may lead to cognitive impairment 50929 3Independent Provider Sponsored Administrative Cost Trends Increase in 2008 as Ratios Decrease on Product Mix Change 50926 1Independent Provider Sponsored Administrative Cost Trends Increase in 2008 as Ratios Decrease on Product Mix Change 50926 2Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 1Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 2Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 3Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 4
...clinical trials have determined that milk thistle ... not have any significant influence on the course ...tis B or C liver disease. These findings are publ... , According to the previous studies, milk thistle...at protect against various hepatotoxins, including...
...ough the open state of a membrane-protein,s ion ch... Illinois at Urbana-Champaign to obtain a detailed...ment on the affinity of ionizable amino-acid resid...ec. 15 issue of Nature, are expected to be welcome...entalists and theoreticians, because they have pre...
...Primate Research Center at Oregon Health & Sci...e that appears to control how stem cells become va...icant implications for the study of Parkinson,s di...ditions or diseases that might be combated by repl... published in the current online edition of the me...
Other Biology News:New technique helps researchers determine amino-acid charge 2OHSU discovery sheds light into how stem cells become brain cells 2
FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Human Cytokine Antibody Array 1.1 (4) Kit, RayBio from Raybiotech, Inc.
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Biology Products: